Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products

Bacteriophages are novel safe and efficacious medicinal products that are used for treatment of intestinal infections and purulent inflammations. The fact that virulent phages can be adapted to fight antibiotic-resistant bacterial strains makes this group of medicines a promising means of treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: T. M. Kargina, E. I. Sakanyan, D. S. Davydov, R. L. Parfenyuk
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-12-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/237
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242989655752704
author T. M. Kargina
E. I. Sakanyan
D. S. Davydov
R. L. Parfenyuk
author_facet T. M. Kargina
E. I. Sakanyan
D. S. Davydov
R. L. Parfenyuk
author_sort T. M. Kargina
collection DOAJ
description Bacteriophages are novel safe and efficacious medicinal products that are used for treatment of intestinal infections and purulent inflammations. The fact that virulent phages can be adapted to fight antibiotic-resistant bacterial strains makes this group of medicines a promising means of treatment of infections associated with medical interventions. The elaboration of quality standards for bacteriophage products will enable alignment of the quality requirements and test methods. There are no monographs on bacteriophage products in pharmacopoeias of other countries, therefore, the development of general chapters on groups of test methods used in bacteriophage quality control and monographs on bacteriophages for the State Pharmacopoeia of the Russian Federation (Ph. Rus.) was a very relevant and timely initiative. The aim of the study was to elaborate pharmacopoeial quality standards for bacteriophages approved in the Russian Federation for therapeutic and prophylactic indications. The authors of the study analysed product specification files and master production records for bacteriophages produced in the Russian Federation. They determined common GMP-compliant production steps, the selection criteria for bacteriophage strains and bacteria production strains, and cultivation and storage conditions. The authors standardised bacteriophage quality parameters and brought the test methods in line with the test procedures described in the Ph. Rus., 14th ed. The study summarised test methods used for identification of bacteriophages and determination of their specific activity. The main results of the study were included into the general monograph «Bacteriophages» and individual monographs on bacteriophage products that were included into the current edition of the Ph. Rus. Further studies and elaboration of new quality standards for mono- and multicomponent bacteriophage products, and the use of such products in clinical practice will improve prophylaxis and treatment of various infectious diseases.
format Article
id doaj-art-21c8a5abde414d55996e02aed955d931
institution Kabale University
issn 2221-996X
2619-1156
language Russian
publishDate 2019-12-01
publisher Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Биопрепараты: Профилактика, диагностика, лечение
spelling doaj-art-21c8a5abde414d55996e02aed955d9312025-08-20T03:59:39ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562019-12-0119423324110.30895/2221-996X-2019-19-4-233-241194Elaboration of Pharmacopoeial Quality Standards for Bacteriophage ProductsT. M. Kargina0E. I. Sakanyan1D. S. Davydov2R. L. Parfenyuk3Scientific Centre for Expert Evaluation of Medicinal ProductsScientific and Production Association for Immunological Preparations «Microgen»Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsBacteriophages are novel safe and efficacious medicinal products that are used for treatment of intestinal infections and purulent inflammations. The fact that virulent phages can be adapted to fight antibiotic-resistant bacterial strains makes this group of medicines a promising means of treatment of infections associated with medical interventions. The elaboration of quality standards for bacteriophage products will enable alignment of the quality requirements and test methods. There are no monographs on bacteriophage products in pharmacopoeias of other countries, therefore, the development of general chapters on groups of test methods used in bacteriophage quality control and monographs on bacteriophages for the State Pharmacopoeia of the Russian Federation (Ph. Rus.) was a very relevant and timely initiative. The aim of the study was to elaborate pharmacopoeial quality standards for bacteriophages approved in the Russian Federation for therapeutic and prophylactic indications. The authors of the study analysed product specification files and master production records for bacteriophages produced in the Russian Federation. They determined common GMP-compliant production steps, the selection criteria for bacteriophage strains and bacteria production strains, and cultivation and storage conditions. The authors standardised bacteriophage quality parameters and brought the test methods in line with the test procedures described in the Ph. Rus., 14th ed. The study summarised test methods used for identification of bacteriophages and determination of their specific activity. The main results of the study were included into the general monograph «Bacteriophages» and individual monographs on bacteriophage products that were included into the current edition of the Ph. Rus. Further studies and elaboration of new quality standards for mono- and multicomponent bacteriophage products, and the use of such products in clinical practice will improve prophylaxis and treatment of various infectious diseases.https://www.biopreparations.ru/jour/article/view/237bacteriophagesmedicinal productsgeneral chaptergeneral monographmonographtest methodsquality parameters
spellingShingle T. M. Kargina
E. I. Sakanyan
D. S. Davydov
R. L. Parfenyuk
Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
Биопрепараты: Профилактика, диагностика, лечение
bacteriophages
medicinal products
general chapter
general monograph
monograph
test methods
quality parameters
title Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
title_full Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
title_fullStr Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
title_full_unstemmed Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
title_short Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products
title_sort elaboration of pharmacopoeial quality standards for bacteriophage products
topic bacteriophages
medicinal products
general chapter
general monograph
monograph
test methods
quality parameters
url https://www.biopreparations.ru/jour/article/view/237
work_keys_str_mv AT tmkargina elaborationofpharmacopoeialqualitystandardsforbacteriophageproducts
AT eisakanyan elaborationofpharmacopoeialqualitystandardsforbacteriophageproducts
AT dsdavydov elaborationofpharmacopoeialqualitystandardsforbacteriophageproducts
AT rlparfenyuk elaborationofpharmacopoeialqualitystandardsforbacteriophageproducts